Two best friends tell each other true crime stories they think the other hasn't heard yet. Each week, Amanda and Keith tell each other about some of the most egregious crimes - heard this one before?
…
continue reading
Your no bullsh$t guide to divorce with experienced attorneys from New Direction Family Law and guests and professionals who have been there. Unfiltered discussions to help you move from victim to victorious and from bitter to better.
…
continue reading
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
Hear short, contemporary stage plays with first-rate casts. Playing on Air brings together award winners and emerging young talent, and each play is followed by a conversation with the playwrights and cast. Tune in for great American plays with great American actors, hosted and produced by Claudia Catania.
…
continue reading
Dive into entrepreneurship with Lessons via Leaders, a biweekly podcast featuring raw and real stories from top business leaders. Uncover their secrets to success and learn valuable lessons as you grow. Subscribe, leave a review, and follow @lessonsvialeaders on Instagram for exclusive content. Lead with purpose and create positive change! 🧭🚀
…
continue reading
Our laws and ethical practices have evolved over centuries. But today, tech is on an exponential curve and is affecting practically everyone—everywhere, pulling society from its roots and reordering the way we live. Amidst these changes, how do we make sure our laws keep pace with the times? Join Yves Faguy of CBA National in conversation with leading legal minds and practitioners exploring this question. -- Nos lois et nos pratiques en matière d'éthique ont évolué au fil des siècles. Mais a ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Payer-Provider Partnership Tackles Behavioral Health of Complex Patients Through Virtual Care with Michelle Clavecilla-Chan MVP Health Care and Amanda Conway Aptihealth TRANSCRIPT
Michelle Clavecilla-Chan, Director of Behavioral Health at MVP Health Care, and Amanda Conway, Chief Growth Officer at Aptihealth, have partnered to expand access to mental health services for MVP customers. Aptihealth provides virtual behavioral health services that connect patients to comprehensive mental health and substance abuse support. Throu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Payer-Provider Partnership Tackles Behavioral Health of Complex Patients Through Virtual Care with Michelle Clavecilla-Chan MVP Health Care and Amanda Conway Aptihealth
19:35
19:35
Play later
Play later
Lists
Like
Liked
19:35
Michelle Clavecilla-Chan, Director of Behavioral Health at MVP Health Care, and Amanda Conway, Chief Growth Officer at Aptihealth, have partnered to expand access to mental health services for MVP customers. Aptihealth provides virtual behavioral health services that connect patients to comprehensive mental health and substance abuse support. Throu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Functional Medicine Approach Focuses on Finding Root Causes of Diseases with Martin Pytela Metabolic Typing Advisor TRANSCRIPT
Martin Pytela is a functional medicine expert, metabolic typing coach, and fellow podcaster. He discusses the principles of functional medicine and its focus on finding the root causes of health issues rather than just treating symptoms. Understanding metabolic behavior and how it can affect emotional well-being and overall health highlights the ne…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Functional Medicine Approach Focuses on Finding Root Causes of Diseases with Martin Pytela Metabolic Typing Advisor
19:25
19:25
Play later
Play later
Lists
Like
Liked
19:25
Martin Pytela is a functional medicine expert, metabolic typing coach, and fellow podcaster. He discusses the principles of functional medicine and its focus on finding the root causes of health issues rather than just treating symptoms. Understanding metabolic behavior and how it can affect emotional well-being and overall health highlights the ne…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Leveraging AI to Enhance Healthcare Contact Center Productivity and Patient Engagement with Patty Hayward Talkdesk TRANSCRIPT
Patty Hayward, general manager for healthcare and life sciences at Talkdesk, talks about transforming the traditional call center into one that uses AI and large language models to make it easier for patients to get help and free up call center staff to focus on value-added tasks. The technology supports call center agents in their conversations wi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Leveraging AI to Enhance Healthcare Contact Center Productivity and Patient Engagement with Patty Hayward Talkdesk
17:44
17:44
Play later
Play later
Lists
Like
Liked
17:44
Patty Hayward, general manager for healthcare and life sciences at Talkdesk, talks about transforming the traditional call center into one that uses AI and large language models to make it easier for patients to get help and free up call center staff to focus on value-added tasks. The technology supports call center agents in their conversations wi…
…
continue reading
AJ Tesler, an award-winning producer and director who, along with his wife Jenny, is launching Magnolia’s Guide to Adventuring, a new documentary video series created with support from Acadia Pharmaceuticals, inspired by their daughter Magnolia’s experience with the rare genetic neurodevelopmental disease Rett syndrome. We’re also joined by Dr. Car…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Customized Adventures for Kids with Rett Syndrome with AJ Tesler and Dr. Cary Fu
18:43
18:43
Play later
Play later
Lists
Like
Liked
18:43
AJ Tesler, an award-winning producer and director who, along with his wife Jenny, is launching Magnolia’s Guide to Adventuring, a new documentary video series created with support from Acadia Pharmaceuticals, inspired by their daughter Magnolia’s experience with the rare genetic neurodevelopmental disease Rett syndrome. We’re also joined by Dr. Car…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Improving Targeting and Penetration of Cancer Therapies for Solid Tumors by Modifying Tumor Microenvironment with David Mazzo Lisata Therapeutics TRANSCRIPT
David Mazzo, President and CEO of Lisata Therapeutics, has a lead program focused on metastatic pancreatic ductal adenocarcinoma. The Lisata CendR Platform and drug certepetide efficiently augment the effects of chemotherapy and immunotherapies in the tumor microenvironment. Based on early findings, the future of cancer treatment may involve combin…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Improving Targeting and Penetration of Cancer Therapies for Solid Tumors by Modifying Tumor Microenvironment with David Mazzo Lisata Therapeutics
18:04
18:04
Play later
Play later
Lists
Like
Liked
18:04
David Mazzo, President and CEO of Lisata Therapeutics, has a lead program focused on metastatic pancreatic ductal adenocarcinoma. The Lisata CendR Platform and drug certepetide efficiently augment the effects of chemotherapy and immunotherapies in the tumor microenvironment. Based on early findings, the future of cancer treatment may involve combin…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Redefining Pain Management with Innovative Salonpas OTC Topical Analgesics with John Incledon Hisamitsu America TRANSCRIPT
John Incledon, President and CEO of Hisamitsu America, the makers of Salonpas, has seen enormous growth in the acceptance of over-the-counter topical pain management options since introducing the Salonpas analgesic patch in the US market 37 years ago. This growth is partly due to television ads featuring doctors touting the benefits of Salonpas for…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Redefining Pain Management with Innovative Salonpas OTC Topical Analgesics with John Incledon Hisamitsu America
22:28
22:28
Play later
Play later
Lists
Like
Liked
22:28
John Incledon, President and CEO of Hisamitsu America, the makers of Salonpas, has seen enormous growth in the acceptance of over-the-counter topical pain management options since introducing the Salonpas analgesic patch in the US market 37 years ago. This growth is partly due to television ads featuring doctors touting the benefits of Salonpas for…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Tech-Enabled Measurement-Informed Behavioral Healthcare Includes Therapy and Psychiatry with Dr. Doug Newton Rula Health TRANSCRIPT
Dr. Doug Newton is the Chief Medical Officer at Rula Health, a tech-enabled provider group that offers therapy, psychiatry, care coordination, and other supportive behavioral health services with a whole-person approach. Mental health disorders are diagnosed and managed using a combination of sound clinical judgment and measurement-informed care, w…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Tech-Enabled Measurement-Informed Behavioral Healthcare Includes Therapy and Psychiatry with Dr. Doug Newton Rula Health
18:50
18:50
Play later
Play later
Lists
Like
Liked
18:50
Dr. Doug Newton is the Chief Medical Officer at Rula Health, a tech-enabled provider group that offers therapy, psychiatry, care coordination, and other supportive behavioral health services with a whole-person approach. Mental health disorders are diagnosed and managed using a combination of sound clinical judgment and measurement-informed care, w…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Power of Personalized Polygenic Risk Scores to Predict and Prevent Diseases with Professor Sir Peter Donnelly Genomics plc TRANSCRIPT
Professor Sir Peter Donnelly, Founder and CEO of Genomics plc, aims to use cutting-edge polygenic risk scores to identify inherited DNA mutations and genetic predispositions that could lead to common diseases. In partnership with the MassMutual life insurance company, Genomics offers a voluntary test that provides personalized risk measures and adv…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Power of Personalized Polygenic Risk Scores to Predict and Prevent Diseases with Professor Sir Peter Donnelly Genomics plc
18:02
18:02
Play later
Play later
Lists
Like
Liked
18:02
Professor Sir Peter Donnelly, Founder and CEO of Genomics plc, aims to use cutting-edge polygenic risk scores to identify inherited DNA mutations and genetic predispositions that could lead to common diseases. In partnership with the MassMutual life insurance company, Genomics offers a voluntary test that provides personalized risk measures and adv…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Platform to Address Loneliness and Improve Care for Chronic Diseases with Oren Nissim Brook Health TRANSCRIPT
Oren Nissim, CEO and Co-Founder of Brook Health focuses on loneliness and its impact on individuals with chronic conditions, especially when access to support is limited. Societal stigma and guilt associated with chronic conditions often contribute to loneliness, which can include depression, lack of agency, and a sense of being alone. Brook Health…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Platform to Address Loneliness and Improve Care for Chronic Diseases with Oren Nissim Brook Health
18:26
18:26
Play later
Play later
Lists
Like
Liked
18:26
Oren Nissim, CEO and Co-Founder of Brook Health focuses on loneliness and its impact on individuals with chronic conditions, especially when access to support is limited. Societal stigma and guilt associated with chronic conditions often contribute to loneliness, which can include depression, lack of agency, and a sense of being alone. Brook Health…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Computational Biology Accelerating Cell and Gene Therapy Development with Kent Wakeford Form Bio TRANSCRIPT
Kent Wakeford, Co-CEO and Co-Founder of Form Bio, a company that provides computational solutions to scientists who are focused on cell and gene therapy to accelerate drug discovery and development, reduce costs, and ultimately make treatments more affordable for patients. Form Bio's in silico platform utilizes computational biology tools, bioinfor…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Computational Biology Accelerating Cell and Gene Therapy Development with Kent Wakeford Form Bio
18:59
18:59
Play later
Play later
Lists
Like
Liked
18:59
Kent Wakeford, Co-CEO and Co-Founder of Form Bio, a company that provides computational solutions to scientists who are focused on cell and gene therapy to accelerate drug discovery and development, reduce costs, and ultimately make treatments more affordable for patients. Form Bio's in silico platform utilizes computational biology tools, bioinfor…
…
continue reading
Ram Krishnan, CEO of Valant, works with therapists, psychologists, psychiatrists, and nurse practitioners in the outpatient behavioral healthcare environment, which has significant unmet needs that can be addressed with technology. Scaling a mental health practice differs from other medical practices due to the frequency of visits and the need for …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scaling Behavioral Healthcare Practices Using Generative AI with Ram Krishnan Valant
19:36
19:36
Play later
Play later
Lists
Like
Liked
19:36
Ram Krishnan, CEO of Valant, works with therapists, psychologists, psychiatrists, and nurse practitioners in the outpatient behavioral healthcare environment, which has significant unmet needs that can be addressed with technology. Scaling a mental health practice differs from other medical practices due to the frequency of visits and the need for …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Decision Intelligence Platform Uses AI to Guide Healthcare Treatment Choices with Fadi Micaelian Sparkdit and Dr. Andrew Fang TRANSCRIPT
Fadi Micaelian, CEO of Sparkdit, and Dr. Andrew Fang, Chief of Orthopedics at Kaiser South San Francisco, have joined together to help patients and doctors make better treatment decisions by considering trade-offs and patient preferences. The platform can help reduce bias and incorporate patient desires into care while considering comorbidities and…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Decision Intelligence Platform Uses AI to Guide Healthcare Treatment Choices with Fadi Micaelian Sparkdit and Dr. Andrew Fang
22:43
22:43
Play later
Play later
Lists
Like
Liked
22:43
Fadi Micaelian, CEO of Sparkdit, and Dr. Andrew Fang, Chief of Orthopedics at Kaiser South San Francisco, have joined together to help patients and doctors make better treatment decisions by considering trade-offs and patient preferences. The platform can help reduce bias and incorporate patient desires into care while considering comorbidities and…
…
continue reading
Sufian Chowdhury, CEO of Kinetik, highlights how the non-emergency medical transportation industry, which has about 20,000 local transportation providers and over 400,000 drivers, plays a pivotal role in the healthcare continuum. Kinetik is bringing digital tools to this environment to provide scheduling and real-time information to an industry tha…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Streamlining Non-Emergency Medical Transportation with Sufian Chowdhury Kinetik
16:49
16:49
Play later
Play later
Lists
Like
Liked
16:49
Sufian Chowdhury, CEO of Kinetik, highlights how the non-emergency medical transportation industry, which has about 20,000 local transportation providers and over 400,000 drivers, plays a pivotal role in the healthcare continuum. Kinetik is bringing digital tools to this environment to provide scheduling and real-time information to an industry tha…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI-Enabled Digital Front Door Technology Changing Patient Care Navigation and Nurse Triage with Piotr Orzechowski Infermedica TRANSCRIPT
Piotr Orzechowski, CEO of Infermedica, works with health insurance companies, technology partners, public payers, and ministries of health to provide digital care navigation tools that enhance the patient experience with a healthcare provider. The highlight is the development of digital front door technology to support patients in finding appropria…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI-Enabled Digital Front Door Technology Changing Patient Care Navigation and Nurse Triage with Piotr Orzechowski Infermedica
19:12
19:12
Play later
Play later
Lists
Like
Liked
19:12
Piotr Orzechowski, CEO of Infermedica, works with health insurance companies, technology partners, public payers, and ministries of health to provide digital care navigation tools that enhance the patient experience with a healthcare provider. The highlight is the development of digital front door technology to support patients in finding appropria…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Incorporating Patient Perspective in Clinical Trial Design and Drug Development with Dr. Oren Cohen Fortrea TRANSCRIPT
Dr. Oren Cohen, President of Clinical Pharmacology and Chief Medical Officer at Fortrea, a global CRO spun-off from Labcorp, discusses the contract research environment and how it continues to change to meet the need for increased productivity in the development and testing of new drugs, devices, and treatments. One key goal is to work in close par…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Incorporating Patient Perspective in Clinical Trial Design and Drug Development with Dr. Oren Cohen Fortrea
21:37
21:37
Play later
Play later
Lists
Like
Liked
21:37
Dr. Oren Cohen, President of Clinical Pharmacology and Chief Medical Officer at Fortrea, a global CRO spun-off from Labcorp, discusses the contract research environment and how it continues to change to meet the need for increased productivity in the development and testing of new drugs, devices, and treatments. One key goal is to work in close par…
…
continue reading
Dr. Will Chou, President and CEO of Passage Bio, is developing gene therapies for neurodegenerative diseases, with their lead product being PBFTO2, an AAV gene therapy for a specific genetic variant of frontotemporal dementia. They are also exploring the potential of raising progranulin levels to help patients with other neurodegenerative diseases.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Gene Therapies for Treating Neurodegenerative Diseases with Dr. Will Chou Passage Bio
18:40
18:40
Play later
Play later
Lists
Like
Liked
18:40
Dr. Will Chou, President and CEO of Passage Bio, is developing gene therapies for neurodegenerative diseases, with their lead product being PBFTO2, an AAV gene therapy for a specific genetic variant of frontotemporal dementia. They are also exploring the potential of raising progranulin levels to help patients with other neurodegenerative diseases.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Oral Treatment for Rare Autoimmune Diseases with Ben Zimmer Priovant Therapeutics TRANSCRIPT
Ben Zimmer, CEO of Priovant Therapeutics, focuses on developing therapies for rare autoimmune diseases specifically dermatomyositis, which affects the skin, muscles, and organs, and non-infectious uveitis, a severe ocular inflammatory condition. While these conditions are symptomatically different, mechanistically, they have features in common rela…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Oral Treatment for Rare Autoimmune Diseases with Ben Zimmer Priovant Therapeutics
17:41
17:41
Play later
Play later
Lists
Like
Liked
17:41
Ben Zimmer, CEO of Priovant Therapeutics, focuses on developing therapies for rare autoimmune diseases specifically dermatomyositis, which affects the skin, muscles, and organs, and non-infectious uveitis, a severe ocular inflammatory condition. While these conditions are symptomatically different, mechanistically, they have features in common rela…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Antibacterial Surface Technology Prevents Infections from Implanted Medical Devices with David Nichols Orthobond TRANSCRIPT
David Nichols, CEO of Orthobond aims to address the unmet need of medical device infection and contamination due to bacteria preventing devices from bonding to the bone or tissue. Orthobond's solution is the Ostaguard technology, which uses a molecule with a positive charge to attract and rupture bacteria. The technology is effective against common…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Antibacterial Surface Technology Prevents Infections from Implanted Medical Devices with David Nichols Orthobond
16:24
16:24
Play later
Play later
Lists
Like
Liked
16:24
David Nichols, CEO of Orthobond aims to address the unmet need of medical device infection and contamination due to bacteria preventing devices from bonding to the bone or tissue. Orthobond's solution is the Ostaguard technology, which uses a molecule with a positive charge to attract and rupture bacteria. The technology is effective against common…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Facilitating Innovation and Bringing Operational Efficiencies to Drug Development and Commercialization with Anupam Girdhar Ascential Technologies TRANSCRIPT
Anupam Girdhar, CEO of medical and life sciences at Ascential Technologies, provides contract manufacturing services primarily to Fortune 100 companies, focusing on solving the most complex drug development and manufacturing challenges. By aligning with customers early on to understand the scope and risks of a project, Ascential can save time and m…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Facilitating Innovation and Bringing Operational Efficiencies to Drug Development and Commercialization with Anupam Girdhar Ascential Technologies
16:55
16:55
Play later
Play later
Lists
Like
Liked
16:55
Anupam Girdhar, CEO of medical and life sciences at Ascential Technologies, provides contract manufacturing services primarily to Fortune 100 companies, focusing on solving the most complex drug development and manufacturing challenges. By aligning with customers early on to understand the scope and risks of a project, Ascential can save time and m…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Eye Drop Targets Unmet Need in Pterygium Treatment with Dr. Abu Abraham Cloudbreak Pharma TRANSCRIPT
Dr. Abu Abraham, Chief Medical Officer at Cloudbreak Pharma, discusses the disease burden and gaps in care for patients with Pterygium, also known as Surfer's eye. Pterygium is an ocular surface disorder that creates a growth on the eye's surface that can cause vision problems. The condition is more prevalent in individuals over 40, but it can also…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Eye Drop Targets Unmet Need in Pterygium Treatment with Dr. Abu Abraham Cloudbreak Pharma
15:40
15:40
Play later
Play later
Lists
Like
Liked
15:40
Dr. Abu Abraham, Chief Medical Officer at Cloudbreak Pharma, discusses the disease burden and gaps in care for patients with Pterygium, also known as Surfer's eye. Pterygium is an ocular surface disorder that creates a growth on the eye's surface that can cause vision problems. The condition is more prevalent in individuals over 40, but it can also…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Teaching AI to Think Like Humans and Make Trade-Offs will Transform Healthcare with Fadi Micaelian Sparkdit TRANSCRIPT
Fadi Micaelian, CEO of Sparkdit, teaches machines to think like humans by understanding trade-offs. AI is not good at finding nuance and capturing trade-offs, which is where Sparkdit comes in. They have developed a technology that can teach computers to make trade-offs like humans and put humans at the center of the technology rather than replacing…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Teaching AI to Think Like Humans and Make Trade-Offs will Transform Healthcare with Fadi Micaelian Sparkdit
18:46
18:46
Play later
Play later
Lists
Like
Liked
18:46
Fadi Micaelian, CEO of Sparkdit, teaches machines to think like humans by understanding trade-offs. AI is not good at finding nuance and capturing trade-offs, which is where Sparkdit comes in. They have developed a technology that can teach computers to make trade-offs like humans and put humans at the center of the technology rather than replacing…
…
continue reading
Episode 69... nice. Amanda and Keith discuss what it means to have strong friendships as adults. They also discuss burritos made incorrectly, and lawyers named Lawyer. Keith then tells the story of an American Serial Killer with strong ties in Canada. Sources: https://en.wikipedia.org/wiki/Gary_Allen_Srery https://www.aptnnews.ca/national-news/seri…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Harnessing the Power of Bioactives to Improve Health Outcomes with Sofia Elizondo Brightseed TRANSCRIPT
Sofia Elizondo, COO and Co-Founder of Brightseed, discusses the company's focus on bioactives and their potential to improve health outcomes. Bioactives are small molecules found in nature, such as plants, fungi, or bacteria, that activate human biological receptors and positively affect the body. Brightseed uses its AI platform, Forager, to identi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Harnessing the Power of Bioactives to Improve Health Outcomes with Sofia Elizondo Brightseed
17:57
17:57
Play later
Play later
Lists
Like
Liked
17:57
Sofia Elizondo, COO and Co-Founder of Brightseed, discusses the company's focus on bioactives and their potential to improve health outcomes. Bioactives are small molecules found in nature, such as plants, fungi, or bacteria, that activate human biological receptors and positively affect the body. Brightseed uses its AI platform, Forager, to identi…
…
continue reading
Luke Piggott, principal scientist at Debiopharm, has a unique business model in the drug discovery and development to commercialization landscape. Focusing on rare cancers, they license drugs from smaller biotechs and conduct clinical trials before out-licensing them to larger pharmaceutical companies with marketing capabilities. The use of AI is e…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bridging the Gap Between Drug Discovery and Marketing with Luke Piggott Debiopharm
15:50
15:50
Play later
Play later
Lists
Like
Liked
15:50
Luke Piggott, principal scientist at Debiopharm, has a unique business model in the drug discovery and development to commercialization landscape. Focusing on rare cancers, they license drugs from smaller biotechs and conduct clinical trials before out-licensing them to larger pharmaceutical companies with marketing capabilities. The use of AI is e…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Providing Financial Assistance to Patients with Rare Diseases and Chronic Conditions with Tiara Green Accessia Health TRANSCRIPT
Tiara Green, President of Accessia Health, provides financial assistance for copayments, physician visits, durable medical equipment, radiology testing, and travel expenses to support individuals with rare and chronic healthcare conditions who cannot afford their care. They also offer educational services to help patients navigate the healthcare sy…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Providing Financial Assistance to Patients with Rare Diseases and Chronic Conditions with Tiara Green Accessia Health
15:07
15:07
Play later
Play later
Lists
Like
Liked
15:07
Tiara Green, President of Accessia Health, provides financial assistance for copayments, physician visits, durable medical equipment, radiology testing, and travel expenses to support individuals with rare and chronic healthcare conditions who cannot afford their care. They also offer educational services to help patients navigate the healthcare sy…
…
continue reading